Skip to main content
Erschienen in: Reactions Weekly 1/2012

01.08.2012 | Case report

Eculizumab withdrawal

Thrombosis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat van Bijnen STA, van Rijn RS, Koljenovic S, te Boekhorst P, De Witte T, Muus P.Possible high risk of thrombotic events in patients with paroxysmal nocturnal haemoglobinuria after discontinuation of eculizumab. British Journal of Haematology 157: 762-763, No. 6, Jun 2012. Available from: URL: http://dx.doi.org/10.1111/j.1365-2141.2012.09073.x - Netherlands van Bijnen STA, van Rijn RS, Koljenovic S, te Boekhorst P, De Witte T, Muus P.Possible high risk of thrombotic events in patients with paroxysmal nocturnal haemoglobinuria after discontinuation of eculizumab. British Journal of Haematology 157: 762-763, No. 6, Jun 2012. Available from: URL: http://​dx.​doi.​org/​10.​1111/​j.​1365-2141.​2012.​09073.​x - Netherlands
Metadaten
Titel
Eculizumab withdrawal
Thrombosis: case report
Publikationsdatum
01.08.2012
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2012
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201214140-00077

Weitere Artikel der Ausgabe 1/2012

Reactions Weekly 1/2012 Zur Ausgabe

Case report

Telaprevir

Case report

Capecitabine

Case report

Adalimumab

Case report

Nitrofurantoin